News2018-08-06T13:17:10+00:00

NEWS ARCHIVE

NEWS

Tech start-up MetisMotion receives more than one million Euro in first investment round

December 13th, 2018|Comments Off on Tech start-up MetisMotion receives more than one million Euro in first investment round

The Munich-based tech start-up MetisMotion has received more than one million Euro in fresh capital in its first financing round. The investors are High-Tech Gründerfonds (HTGF), BORN2GROW Seedfonds - a subsidiary of ZFHN Zukunftsfonds Heilbronn [...]

Perfect Launch for Inspecto

November 13th, 2018|Comments Off on Perfect Launch for Inspecto

Our portfolio company from Israel had a perfect product launch at the "Vision" trade fair in Stuttgart. The world's first Autonomous Machine Vision System will revolutionize the world of quality control in industrial manufacturing. The [...]

SWR film about ZFHN is published

November 5th, 2018|Comments Off on SWR film about ZFHN is published

For almost 30 minutes, in "Die Zukunftsmacher-Auf der Jagd nach Start-ups für Heilbronn (The future makers - on the hunt for start-ups for Heilbronn)" SWR reports on the cooperation between ZFHN and promising young high-tech companies. [...]

SWR Television broadcasts about the ZFHN

September 20th, 2018|Comments Off on SWR Television broadcasts about the ZFHN

"Die Heilbronner Zukunftsmacher - Auf der Jagd nach Startup-Unternehmen" is the title of the new SWR television report about the ZFHN Zukunftsfonds Heilbronn, which will be broadcasted on Wednesday, October 31. SWR editor Andrea Lotter [...]

Startup-Valley News reports about ZFHN

September 10th, 2018|Comments Off on Startup-Valley News reports about ZFHN

In its current issue the magazine Startup Valley also reports about the ZFHN. The article focuses on ZFHN's intensive cooperation with Israeli startups and investors. The ZFHN has been cultivating relations with the Israeli start-up scene [...]

Many guests at the traditional summer party

July 26th, 2018|Comments Off on Many guests at the traditional summer party

In bright sunshine, many guests accepted the invitation of the ZFHN Zukunftsfonds Heilbronn to the traditional summer party. ZFHN business partners, national and international investment managers and representatives of business and politics met at the [...]

Compositence GmbH gains GON Holding as strategic partner

August 22nd, 2017|Comments Off on Compositence GmbH gains GON Holding as strategic partner

Chinese advanced material manufacturer GON Holding takes majority stake in Compositence Leonberg, August 22th, 2017 – Compositence GmbH, specializing in innovative Preforming Technologies for Carbon, Glass and other fibre types and supplier of tailored preforms [...]

  • Pressebild Thomas-Villinger-Geschäftsführer-zfhn-Wolfgang-Munz-CEO-dataglobal-Günter-Steffen-Fondsmanager-zfhn (v.l.n.r.)

ZFHN sells its shares in the information management specialist dataglobal

April 11th, 2017|Comments Off on ZFHN sells its shares in the information management specialist dataglobal

Buyer is founder and CEO Wolfgang Munz Heilbronn, April 11, 2017. The zfhn Zukunftsfonds Heilbronn has sold its shares in dataglobal GmbH. Following a management buy-out by Wolfgang Munz, the specialist information management company is [...]

XENIOS AG to be sold to Fresenius Medical Care

October 31st, 2016|Comments Off on XENIOS AG to be sold to Fresenius Medical Care

zfhn Zukunftsfonds Heilbronn brings industry giant in medical technology to Heilbronn – another boost for the technology site Heilbronn, 31 October 2016 – zfhn Zukunftsfonds Heilbronn, one of the largest private venture capitalists in Germany, [...]

DEVELOPMENT OF A CONTINUOUS VARIANT OF GREENOVATION´S BIOPHARMACEUTICAL PRODUCTION PROCESS

June 6th, 2016|Comments Off on DEVELOPMENT OF A CONTINUOUS VARIANT OF GREENOVATION´S BIOPHARMACEUTICAL PRODUCTION PROCESS

Scientists and Engineers have developed a continuous production version of Greenovation`s moss-based manufacturing technology for biopharmaceuticals (BryoTechnology). Now established in small-scale research fermentations, the process delivers valuable data for further scale-up and continuous production with [...]

XENiOS AG Enrolls First Patient in “SynCor” Clinical Trial of its CE-Marked i-cor Device to Treat Cardiogenic Shock

March 29th, 2016|Comments Off on XENiOS AG Enrolls First Patient in “SynCor” Clinical Trial of its CE-Marked i-cor Device to Treat Cardiogenic Shock

HEILBRONN, XENIOS announced today that the first patient has been enrolled in the "SynCor" clinical trial of its CE-marked  i-cor® Synchronized Cardiac Assist System for treating cardiogenic shock. The SynCor trial is a prospective, non-randomized, multi-center, open-label observational study [...]